| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
2 companies
Gibney Anthony S serves as a See Remarks at AURA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 1 sell. Those positions are worth an estimated $1.7M at current prices.
Historically, Gibney Anthony S's trades have earned a below-average insider score of 22/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -32.2%.
The biggest single holding is AURA (~$1.7M) as See Remarks. Net of sales, the recent Form 4 record there shows accumulation of 48,481 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | AURA Aura Biosciences, Inc. | See Remarks | Buy | 50,000 | $4.90 | $245,000.00 | +591.6% | +17.6% | +30.1% | |
| May 16, 2025 | AURA Aura Biosciences, Inc. | See Remarks | Sell | 1,519 | $5.15 | $7,822.85 | -2.6% | +17.6% | +30.1% | |
| Apr 18, 2024 | CLSDQ Clearside Biomedical, Inc. | Director | Buy | 100,000 | $1.30 | $129,664.50 | +1,490% | -8.3% | -34.8% |